Share class: Shenyang Xingqi Pharmaceutical Co.,Ltd.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 175,249,247 119,234,614 ( 68.04 %) 0 68.04 %

Major shareholders: Shenyang Xingqi Pharmaceutical Co.,Ltd.

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
1.055 %
1,988,459 1.055 % 19 M ¥
China Asset Management Co., Ltd.
0.9342 %
1,760,526 0.9342 % 17 M ¥
Franklin Templeton Sealand Fund Management Co., Ltd.
0.6301 %
1,187,337 0.6301 % 11 M ¥
Fullgoal Fund Management Co., Ltd.
0.437 %
823,442 0.437 % 8 M ¥
0.4077 %
768,320 0.4077 % 7 M ¥
China Merchants Fund Management Co., Ltd.
0.3709 %
699,032 0.3709 % 7 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.3673 %
692,140 0.3673 % 7 M ¥
Zhong Ou Asset Management Co., Ltd
0.3544 %
667,917 0.3544 % 6 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.3281 %
618,339 0.3281 % 6 M ¥
Chang Xin Asset Management Co., Ltd.
0.2915 %
549,340 0.2915 % 5 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameEquities%Valuation
3.8 %
1,536,640 3.8 % 15 M ¥

Breakdown by shareholder type

Institutional7.16%
Individuals1.22%
Unknown91.62%

Based on 1000 largest holdings

Geographical origin of shareholders

China
7%
Individuals
1.22%
United Kingdom
0.13%
Hong Kong
0.03%

Based on 1000 largest holdings

Logo Shenyang Xingqi Pharmaceutical Co.,Ltd.
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Company’s main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.
Employees
2,426